ASTRIA THERAPEUTICS INC (ATXS) Stock Cash Flow
NASDAQ:ATXS - Nasdaq - US04635X1028 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -100.04M | -72.89M | -51.83M | -194.91M | -37.30M | |||
| Depreciation Amortization | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -2.46M | -2.41M | 2.65M | -3.31M | 3.37M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 8.41M | 6.86M | 5.65M | 168.07M | 1.45M | |||
| OPERATING CASH FLOW | -94.08M | -68.44M | -43.53M | -30.15M | -32.49M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -25.00K | -90.00K | -20.00K | -30.00K | |||
| Other Investing Activity | -189.82M | 135.08M | -167.04M | -12.53M | 6.33M | |||
| INVESTING CASH FLOW | -190.16M | 135.05M | -167.13M | -12.56M | 6.30M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 245.18M | 88.40M | 144.72M | 104.28M | 40.86M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 245.18M | 88.40M | 144.72M | 104.28M | 40.86M | |||
| CHANGE IN CASH | -39.07M | 155.00M | -65.94M | 61.57M | 14.67M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -94.08M | -68.44M | -43.53M | -30.15M | -32.49M | |||
| Capital Expenditure | N/A | -25.00K | -90.00K | -20.00K | -30.00K | |||
| FREE CASH FLOW | -94.42M | -68.47M | -43.62M | -30.17M | -32.52M | |||
All data in USD